secwatch.observer — SEC 8-K summary
======================================

Issuer:     biote Corp. (BTMD)
CIK:        0001819253
Form:       8-K
Filed at:   2023-05-09T23:59:59+00:00
Accession:  0001193125-23-139561
Event type: earnings
Sentiment:  neutral
Materiality: 0.80
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biote Q1 revenue $44.8M (+20.7%), net loss $21.4M; launches warrant exchange offer
--------------------------------------------------------------------------------

- Revenue $44.8M (+20.7% YoY); gross margin 69.1% (+220 bps).
- Net loss $(21.4)M ($(0.39) per share) vs net income $9.4M in Q1 2022.
- Adjusted EBITDA $13.1M (+12.4% YoY); maintains FY 2023 guidance $190-200M revenue, $56-60M adj EBITDA.
- Offer: each outstanding warrant exchanged for 0.23 common shares; consent to convert remaining at 0.207.
- Parties representing 19.4% of public warrants and 59.3% of private warrants have agreed to tender.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819253/000119312523139561/0001193125-23-139561-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819253/000119312523139561/d474476d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-139561

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer